![]() |
Volumn 12, Issue 4, 2009, Pages 383-396
|
Scaffold-hopping potential of fragment-based de novo design: The chances and limits of variation
|
Author keywords
Building block; De novo design; Drug discovery; Machine learning; Scaffold hopping; Similarity
|
Indexed keywords
1 [5 [(2 CYCLOPROPYL 5,7 DIMETHYLIMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL] 2 THIENYL] 3 CYCLOPENTENECARBOXYLIC ACID;
1' [N (1 CARBOXY 3 PHENYLPROPYL)ALANYL]SPIRO[BICYCLO[2.2.2]OCTANE 2,3' PYRROLIDINE] 5' CARBOXYLIC ACID 1 ETHYL ESTER;
2 METHYL 1 OXO 1H PHENALENE 3 ACETIC ACID;
4 METHYLELLAGATE;
7 (2 ACETYLTHIO 3 PHENYLPROPIONAMIDO) 1,2,3,4,6,7,8,12B OCTAHYDRO 6 OXOPYRIDO[2,1 A][2]BENZAZEPINE 4 CARBOXYLIC ACID;
ALRESTATIN;
AVE 7688;
BENAZEPRIL;
CAPTOPRIL;
CGS 13928;
CILAZAPRIL;
CP 161418;
DANSHENOL B;
DN 108;
E 4030;
ELISARTAN;
ENALAPRIL;
ENALAPRIL MALEATE;
EPALRESTAT;
EU 5476;
FOSINOPRIL;
ICI 158535;
ICI 17071;
KT 3866;
L 159530;
LCY 018;
LIGAND;
LISINOPRIL;
LOSARTAN;
M 16049;
NEOMANOALIDE;
ONO 1;
ONO 3;
PERINDOPRIL;
PRATOSARTAN;
RAMIPRIL;
RHC 345;
RHC 4554;
SA 6817;
SAPRISARTAN;
SPR 210;
SQ 13297;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
UP 25713;
ALGORITHM;
ARTICLE;
COMPUTER PROGRAM;
DRUG DESIGN;
DRUG STRUCTURE;
MACHINE LEARNING;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
ALGORITHMS;
COMPUTER SIMULATION;
DRUG DESIGN;
LIGANDS;
MOLECULAR STRUCTURE;
PHARMACEUTICAL PREPARATIONS;
SOFTWARE;
HUMULUS;
|
EID: 66249097778
PISSN: 13862073
EISSN: None
Source Type: Journal
DOI: 10.2174/138620709788167971 Document Type: Article |
Times cited : (32)
|
References (37)
|